公开(公告)号：US20190136195A1

公开(公告)日：2019-05-09

申请号：US16237399

申请日：2018-12-31

Applicant: Gwo Xi Stem Cell Applied Technology Co., Ltd.

Inventor： Shao-Chih Chiu ,  Wan-Sin Syu ,  Ming-Hsi Chuang ,  Po-Cheng Lin

IPC: C12N5/0775 ,  A61K35/28

Abstract: A composition for treatment of tendonitis is provided. The composition comprises a pretreated adipose derived stem cell (ADSC), wherein the ADSC is pretreated with butylidenephthalide, and the concentration of butylidenephthalide is greater or equal to. The composition of the invention has abilities to repair damaged tendon fiber, enhance tissue regeneration, and decrease inflammation. The invention also provides a method for manufacturing a composition for treatment of tendonitis, comprising culturing an ADSC in a medium containing butylidenephthalide.

公开(公告)号：US20180127722A1

公开(公告)日：2018-05-10

申请号：US15416502

申请日：2017-01-26

Applicant: Gwo Xi Stem Cell Applied Technology Co., Ltd.

Inventor： Shao-Chih Chiu ,  Wan-Sin Syu ,  Ming-Hsi Chuang ,  Po-Cheng Lin

IPC: C12N5/0775 ,  A61K35/28

CPC classification number: C12N5/0667 ,  A61K35/28 ,  C12N2500/30 ,  C12N2500/76

Abstract: A composition for treatment of tendonitis is provided. The composition comprises a pretreated adipose derived stem cell (ADSC), wherein the ADSC is pretreated with butylidenephthalide, and the concentration of butylidenephthalide is greater or equal to. The composition of the invention has abilities to repair damaged tendon fiber, enhance tissue regeneration, and decrease inflammation. The invention also provides a method for manufacturing a composition for treatment of tendonitis, comprising culturing an ADSC in a medium containing butylidenephthalide.